Physician profile
Robin Martin
NPI 1962480285
$1,736.60
in general payments reported to CMS, 2019-2025
16 companies · $399 in 2025
The $399 reported for 2025 was more than what 96% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $171 · 2023: $762 · 2024: $405 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,549 · Education: $16.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,549.31 |
| Education | $16.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $668.80 | 2022-2025 | Entyvio, Gattex, Eohilia |
| Braintree Laboratories, INC. | $163.23 | 2022-2024 | Sutab, Suflave |
| Mirum Pharmaceuticals, INC. | $141.04 | 2023 | Livmarli |
| Pacira Pharmaceuticals Incorporated | $121.82 | 2023 | Exparel |
| Fisher & Paykel Healthcare INC | $101.49 | 2023 | Fisher & Paykel Healthcare |
| Trevena, INC. | $100.00 | 2023 | Olinvyk |
| Ardelyx, INC. | $86.45 | 2025 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $86.20 | 2024 | Dupixent |
| Intercept Pharmaceuticals, INC. | $57.78 | 2022-2023 | Ocaliva |
| Janssen Biotech, INC. | $52.65 | 2022-2023 | Stelara, Remicade, Simponi |
| Qol Medical, LLC | $48.47 | 2025 | Sucraid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.74 | 2024 | Trulance |
| Aimmune Therapeutics, INC. | $20.54 | 2025 | Vowst |
| Redhill Biopharma INC. | $19.59 | 2022 | |
| Celltrion USA INC. | $16.45 | 2024 | Zymfentra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $14.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.